CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-15 | Crowley Elizabeth Sr. VP &CPDO | Grant or award · Incentive Stock Option (right to buy) | +82,000 | 82,000 | ||
| 2017-06-15 | Davis Thomas Andrew Executive VP & CMO | Grant or award · Incentive Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2017-06-15 | KELER TIBOR Executive VP & CSO | Grant or award · Incentive Stock Option (right to buy) | +162,000 | 162,000 | ||
| 2017-06-15 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option (right to buy) | +475,000 | 475,000 | ||
| 2017-06-01 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,869 | $2.83 | $8K | 225,822 |
| 2017-05-01 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,869 | $3.33 | $10K | 228,691 |
| 2017-04-03 | McMahon Gerald PhD Director | Shares withheld for taxes | −2,869 | $3.61 | $10K | 231,560 |
| 2017-03-01 | McMahon Gerald PhD Director | Shares withheld for taxes | −32,927 | $3.54 | $117K | 234,429 |
| 2017-03-01 | MARINO JAMES J Director | Grant or award · Non-Qualified Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2016-12-14 | LaVallee Theresa SVP, Reg.& Precision Medicine | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2016-12-14 | McMahon Gerald PhD Director | Grant or award · Non-Qualified Stock Otion (right to buy) | +8,000 | 8,000 | ||
| 2016-09-02 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion | +10,000 | $2.80 | $28K | 83,586 |
| 2016-09-02 | CATLIN AVERY W Sr. VP & CFO | Exercise or conversion · Employee Stock Option (right to buy) | −10,000 | 25,000 | ||
| 2016-09-02 | KELER TIBOR Executive VP & CSO | Purchase | +3,000 | $3.32 | $10K | 18,868 |
| 2016-06-08 | Wright Richard M. Sr. VP & CCO | Grant or award · Incentive Stock Option | +75,000 | 75,000 | ||
| 2016-06-08 | PEPIN RONALD Sr. VP & CBO | Grant or award · Incentive Stock Option | +67,000 | 67,000 | ||
| 2016-06-08 | CATLIN AVERY W Sr. VP & CFO | Grant or award · Incentive Stock Option | +135,000 | 135,000 | ||
| 2016-06-08 | Davis Thomas Andrew Executive VP & CMO | Grant or award · Incentive Stock Option | +157,000 | 157,000 | ||
| 2016-06-08 | KELER TIBOR Executive VP & CSO | Grant or award · Incentive Stock Option | +162,000 | 162,000 | ||
| 2016-06-08 | Marucci Anthony S President & CEO | Grant or award · Incentive Stock Option | +475,000 | 475,000 |
Page 19 of 32 · 629 trades